Publications in collaboration with researchers from University of Montreal (15)

2024

  1. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study

    The Lancet Oncology, Vol. 25, Núm. 5, pp. 668-682

  2. Stroke in critically ill patients with respiratory failure due to COVID-19: Disparities between low-middle and high-income countries

    Heart and Lung, Vol. 68, pp. 131-144

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

    Critical Care, Vol. 26, Núm. 1

  2. Performance evaluation of the smartphone-based AI cough monitoring app - Hyfe Cough Tracker against solicited respiratory sounds

    F1000Research, Vol. 11

2021

  1. Highlight selection of radiochemistry and radiopharmacy developments by editorial board

    EJNMMI Radiopharmacy and Chemistry, Vol. 6, Núm. 1

  2. Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020)

    EJNMMI Radiopharmacy and Chemistry, Vol. 6, Núm. 1

2020

  1. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1

2019

  1. Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

    The Lancet Haematology, Vol. 6, Núm. 9, pp. e448-e458

2018

  1. Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial

    The Lancet, Vol. 391, Núm. 10137, pp. 2325-2334

2014

  1. Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: A multicentre, randomised, double-blind phase 3 trial

    The Lancet Oncology, Vol. 15, Núm. 11, pp. 1195-1206

  2. The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: A meta-analysis in patients with cancer

    Pharmacogenomics Journal, Vol. 14, Núm. 2, pp. 115-119

2012

  1. Restricciones físicas en UCI: su utilización y percepción de pacientes y familiares

    Enfermeria Intensiva, Vol. 23, Núm. 2, pp. 77-86

2010

  1. La calidad asistencial en cuidados intensivos evaluada por los pacientes mediante la escala SERVQUAL

    Enfermeria Intensiva, Vol. 21, Núm. 1, pp. 3-10

2007

  1. Cuidados del paciente al final de la vida: Ayudas y obstáculos que perciben las enfermeras de Cuidados Intensivos

    Enfermeria Intensiva, Vol. 18, Núm. 1, pp. 3-14